Radiotherapy
AssigneeAlgeta AS
InventorsRoy Larsen, Gjermund Henriksen
Life of this patent
Estimating the term…
Abstract
The invention provides a method of radiation treatment of a human or non-human mammalian subject which comprises administering to said subject a therapeutically, prophylactically or pain-palliating amount of a bone targeting complex of an alpha-particle emitting thorium or actinium radionuclide, e.g. for the treatment of calcified tumors, bone tumors, bones, bone surfaces and soft tissues.
Claims13
A method of radiation treatment of a human or non-human mammalian subject which comprises administering to said subject a therapeutic, prophylactic or pain-palliating amount of a bone-targeting complex of a radionuclide, wherein said radionuclide is an alpha-particle emitting thorium radionuclide or an alpha-particle emitting actinium radionuclide.
A radiopharmaceutical composition comprising a bone-targeting complex of a radionuclide selected from the group consisting of an alpha-particle emitting thorium radionuclide and an alpha-particle emitting actinium radionuclide, and a physiologically acceptable carrier or excipient.
A bone-targeting complex comprising an alpha-particle emitting thorium radionuclide or an alpha-particle emitting actinium radionuclide.
A kit for the treatment of a bone surface or a primary or a metastatic cancer to the skeleton, said kit comprising, an alpha-particle emitting actinium radioisotope, a bone seeking chelator, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.